Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. - Wikidata - wikimedia - TriplyDB

Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production.

Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production.

http://www.wikidata.org/entity/Q34309451

about

Pathogenic Acinetobacter: from the Cell Surface to Infinity and Beyond Bloodstream infections in intensive care unit patients: distribution and antibiotic resistance of bacteria Novel derivatives of polymyxins Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside The structure of apo ArnA features an unexpected central binding pocket and provides an explanation for enzymatic cooperativity Heterogeneous persister cells formation in Acinetobacter baumannii Lipopolysaccharide transport to the cell surface: periplasmic transport and assembly into the outer membrane.Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options Rapid dissemination of colistin and carbapenem resistant Acinetobacter baumannii in Central Greece: mechanisms of resistance, molecular identification and epidemiological data.Anticipating the Unpredictable: A Review of Antimicrobial Stewardship and Acinetobacter Infections Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system.Endotoxin structures in the psychrophiles Psychromonas marina and Psychrobacter cryohalolentis contain distinctive acyl features.Efficacy of the small molecule inhibitor of Lipid II BAS00127538 against Acinetobacter baumannii Update on the Epidemiology, Treatment, and Outcomes of Carbapenem-resistant Acinetobacter infections.LpxC inhibitors as new antibacterial agents and tools for studying regulation of lipid A biosynthesis in Gram-negative pathogens.Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.Different surface charge of colistin-susceptible and -resistant Acinetobacter baumannii cells measured with zeta potential as a function of growth phase and colistin treatment genetic determinants of intrinsic colistin tolerance in Acinetobacter baumannii.Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.Systems-level antimicrobial drug and drug synergy discovery.Immunization with lipopolysaccharide-deficient whole cells provides protective immunity in an experimental mouse model of Acinetobacter baumannii infection.Insertion sequence ISAba11 is involved in colistin resistance and loss of lipopolysaccharide in Acinetobacter baumannii.Colistin and polymyxin B: peas in a pod, or chalk and cheese?Practical agar-based disk potentiation test for detection of fosfomycin-nonsusceptible Escherichia coli clinical isolates producing glutathione S-transferases.Whole-genome sequence of Chryseobacterium oranimense, a colistin-resistant bacterium isolated from a cystic fibrosis patient in France.The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A.Distribution of bla(OXA-23), ISAba , Aminoglycosides resistant genes among burned & ICU patients in Tehran and Sari, Iran Variation in the OC locus of Acinetobacter baumannii genomes predicts extensive structural diversity in the lipooligosaccharide.The transcriptomic response of Acinetobacter baumannii to colistin and doripenem alone and in combination in an in vitro pharmacokinetics/pharmacodynamics model.Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance Multidrug-resistant Acinetobacter spp.: increasingly problematic nosocomial pathogens Reinforcing Lipid A Acylation on the Cell Surface of Acinetobacter baumannii Promotes Cationic Antimicrobial Peptide Resistance and Desiccation Survival In Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic Treatment Colistin-resistant, lipopolysaccharide-deficient Acinetobacter baumannii responds to lipopolysaccharide loss through increased expression of genes involved in the synthesis and transport of lipoproteins, phospholipids, and poly-β-1,6-N-acetylglucosa Membrane-Active Small Molecules: Designs Inspired by Antimicrobial Peptides.The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace.Functional Genome Screening to Elucidate the Colistin Resistance Mechanism.Antibacterial Low Molecular Weight Cationic Polymers: Dissecting the Contribution of Hydrophobicity, Chain Length and Charge to Activity

P2860

Q26771783-3221ED09-2B90-4EA8-BA5F-6DC80328AE20 Q26795565-8B69A4F2-82C1-4272-A0DC-98347C45CC1A Q26824934-D9BEA86F-115E-42D9-BEAD-751305CB9015 Q26991886-7730C9CE-0CDA-40DD-A832-FDBD7651748F Q27015109-81AD4481-FC64-409D-98EF-AA5379D9B70E Q27024893-620E6D06-D499-4873-9479-973EB69AD520 Q27698393-B171CC20-02C1-4A34-9B46-DE70002DAEBD Q28538196-1573B549-11B9-4382-8911-757DC4BB8C9F Q30152829-7C212161-F2AD-4B1F-81AD-3369636AF51E Q30235064-E0C704E1-FC39-4B09-A00C-A1E950B181C5 Q31031386-3ADE2DA7-C73F-4CC5-BD22-2143409C3900 Q33732524-C73925F4-A2FD-4450-B5D8-C3791560B0D0 Q33901939-D1D4D7FA-E98A-4062-ACAA-EA0B1F82397D Q33963584-0E76FAD9-9DA0-474A-BD2F-CA5EECF758A4 Q34049982-37FB1FD4-C976-43B3-BF8B-C58C4B1AC12C Q34168292-96D24780-E9C9-4ABC-8794-9A5CB146ACDA Q34334699-A528E9A2-E283-4077-B92B-E548215EF754 Q34346283-56BDCBF0-9237-4C76-880B-D6DA94E6C511 Q34405889-D472489F-0C3D-482A-B68D-18153CB89786 Q34508304-53963B6B-C8EF-4F58-B1B8-4A7D3C0A9356 Q34552966-1C54F710-79FD-48DB-B586-CC8AFD34DBFB Q34626969-6231BF31-F50F-4A66-98CA-13287EE6F1CC Q34653632-028CEAD1-57DD-4836-85BC-6D4A9F4FF0BC Q35005140-DB849A68-8EB0-4699-BE3D-E66F4A7348FB Q35008357-9314F8ED-070C-4904-8731-94F5A8A7DB7A Q35035695-AFEE5354-BB8E-4EFB-B2B4-1E56A125EEFC Q35076797-6A6C0557-546D-4952-A57C-6E5E9573DA5D Q35139454-E485508C-95E8-4CFD-890E-4E17DA4ED1CC Q35159315-547C0D21-003F-4A77-8C27-BFBF259A2666 Q35270634-6F0D7FA8-F2DE-4234-A2C7-9AA52BF506E7 Q35432662-AAC0A776-AF4F-4DE7-91A9-DEF1F7D30165 Q35551122-7A0C7E8C-10C3-4035-9251-3D76860BAB3C Q35561864-877F64A3-F48E-4AC6-9AE3-26F6BE95F3F6 Q35640103-0B7822EE-528D-4236-AE5A-B7FC5F365F7B Q35662086-7930E1AC-410B-4CBE-A57E-0C038BB16EDF Q35666622-DA3713AC-106E-421F-B22E-BA9A6E496EEA Q35781198-91DB235E-A5B7-47F9-8CF0-71CAC9799A74 Q35905605-1E559F1F-3C3F-436A-A2D0-BEB37ADEEBB6 Q35961832-01AC2C0A-6A69-440F-8754-3AE08DA39BF1 Q35964477-97CA75CD-A9BD-4B75-A85F-1E299F98000C

P2860

Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production.

http://www.wikidata.org/entity/Q34309451

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Colistin resistance in Acineto ...... lipopolysaccharide production.

@ast

Colistin resistance in Acineto ...... lipopolysaccharide production.

@en

Colistin resistance in Acineto ...... lipopolysaccharide production.

@nl

type

label

Colistin resistance in Acineto ...... lipopolysaccharide production.

@ast

Colistin resistance in Acineto ...... lipopolysaccharide production.

@en

Colistin resistance in Acineto ...... lipopolysaccharide production.

@nl

prefLabel

Colistin resistance in Acineto ...... lipopolysaccharide production.

@ast

Colistin resistance in Acineto ...... lipopolysaccharide production.

@en

Colistin resistance in Acineto ...... lipopolysaccharide production.

@nl

P1433

Q34309451-7AB95C67-D5D9-498A-B56D-4E3978D20B87

P1476

Q34309451-B6C65609-63A0-4DBA-AB5E-6E7D39F02717

P2093

Q34309451-0DDB26B3-60AD-4359-B308-1217B0168D16

Q34309451-1F9EC408-BE4C-4619-86F3-6A8C5359E6F8

Q34309451-358CAED0-5AAF-4ECD-9B3A-9E5622AC48BD

Q34309451-383FD939-8FE1-4CA4-AD15-DAC2C035B5EA

Q34309451-42C4B4ED-BD1B-4FBB-92AA-B6FF73C120BF

Q34309451-B799E1AC-238F-4316-ACC3-B5906D6083AF

Q34309451-BB551730-C457-4A6B-854B-26D9EF373A50

Q34309451-C982F6B6-DFC1-4A70-897E-EFBE7C07EA81

P2860

Q34309451-0328536E-AF31-4385-A78E-877117436068

Q34309451-038F3432-5181-49DC-B08F-F00BDFE133B6

Q34309451-24E21091-0A69-4FF2-BBAA-EA22CA192B5F

Q34309451-2FB0D6A7-2362-454C-9A22-3726BF336756

Q34309451-300311FC-B5CF-474D-A2FE-20B979A75F89

Q34309451-36F7A745-1EF7-42FB-A803-AC1BC7804FE6

Q34309451-4D393789-4080-4BFD-8419-F0064E3568B3

Q34309451-563514D0-4E0F-4826-9779-739B9E05556E

Q34309451-5849484A-F493-4A91-899D-463ED9951090

Q34309451-597129E5-FB70-4834-AABA-E1D7BBB30FAE

P304

Q34309451-667D3E10-CD05-41E4-A971-48890ACD4E5F

P31

Q34309451-21658BF9-FC05-4829-9442-926F3AEEF325

P356

Q34309451-18503689-1BA0-46D0-B169-BC77A06441F6

P407

Q34309451-F1475CA7-2E15-41BA-95EF-B88283E689B7

P433

Q34309451-FC3D1016-0230-44A0-8AD6-111792EA37D6

P478

Q34309451-D295B3C5-FF96-4764-89FB-F0022B892909

P50

Q34309451-7167E61E-6FEC-40E7-89E9-EDEF599E7A8A

Q34309451-857A5963-B3E8-4F39-BADF-5B1FA2CFC542

Q34309451-966D8F57-8DAF-42E2-BD57-0BA27DE3F09D

Q34309451-B34B024E-1D1F-4E26-B1A3-17B9CB91FFD9

Q34309451-CC003FB4-9302-496E-BCC9-284241BFEAF6

Q34309451-FD1C5966-95C4-4CBB-B92D-8889E60A66EE

P577

Q34309451-AC46B79E-FFF9-423D-8428-C38846C546AF

P698

Q34309451-D638A215-29E1-4A6F-946F-EBE0C253CAB0

P921

Q34309451-AA53CCCF-E917-42C9-8F75-CDE7C780084F

P932

Q34309451-3D569092-1CAB-4CD8-AEC2-455226420F5A

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Colistin resistance in Acineto ...... lipopolysaccharide production.

@en

P2093

Andrew D Cox

http://www.w3.org/2001/XMLSchema#string

Ben Adler

http://www.w3.org/2001/XMLSchema#string

Bethany Crane

http://www.w3.org/2001/XMLSchema#string

Frank St Michael

http://www.w3.org/2001/XMLSchema#string

Jennifer H Moffatt

http://www.w3.org/2001/XMLSchema#string

John D F Hale

http://www.w3.org/2001/XMLSchema#string

Paul Harrison

http://www.w3.org/2001/XMLSchema#string

Roger L Nation

http://www.w3.org/2001/XMLSchema#string

P2860

Fis is essential for capsule production in Pasteurella multocida and regulates expression of other important virulence factors

SHRiMP: accurate mapping of short color-space reads

Moraxella catarrhalis bacterium without endotoxin, a potential vaccine candidate

Lipid A modification systems in gram-negative bacteria

Velvet: algorithms for de novo short read assembly using de Bruijn graphs

Cleavage of structural proteins during the assembly of the head of bacteriophage T4

Nucleotide substrate recognition by UDP-N-acetylglucosamine acyltransferase (LpxA) in the first step of lipid A biosynthesis

Structural basis for the acyl chain selectivity and mechanism of UDP-N-acetylglucosamine acyltransferase

Molecular basis of bacterial outer membrane permeability revisited

Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria.

P304

4971-4977

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00834-10

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

Torsten Seemann

Evgeny V Vinogradov

P577

2010-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20855724

http://www.w3.org/2001/XMLSchema#string

P921

lipopolysaccharide

P932

2981238

http://www.w3.org/2001/XMLSchema#string